Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation

BACKGROUND/AIMS: BK virus (BKV) has been associated with late-onset hemorrhagic cystitis (HC) in recipients of hematopoietic stem cell transplantation (HSCT). Cidofovir has been used at higher doses (3 to 5 mg/kg/wk) with probenecid prophylaxis; however, cidofovir may result in nephrotoxicity or cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung-Shin, Ahn, Jae-Sook, Jung, Sung-Hoon, Ahn, Seo-Yeon, Kim, Jae-Yong, Jang, Hee-Chang, Kang, Seung-Ji, Jang, Mi-Ok, Yang, Deok-Hwan, Kim, Yeo-Kyeoung, Lee, Je-Jung, Kim, Hyeoung-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351328/
https://www.ncbi.nlm.nih.gov/pubmed/25750563
http://dx.doi.org/10.3904/kjim.2015.30.2.212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351328/
https://www.ncbi.nlm.nih.gov/pubmed/25750563
http://dx.doi.org/10.3904/kjim.2015.30.2.212

Ejemplares similares